Publications in collaboration with researchers from Hospital Universitario de Salamanca (200)

2024

  1. Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74

2023

  1. Analysis of the degree of implementation of medication error prevention practices in Spanish hospitals (2022)

    Farmacia Hospitalaria, Vol. 47, Núm. 6, pp. 268-276

  2. Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry

    Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91

  3. Medication delivery errors in outpatients with percutaneous endoscopic gastrostomy: effect on tube feeding replacement

    Scientific Reports, Vol. 13, Núm. 1

  4. Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety

    American Journal of Gastroenterology, Vol. 118, Núm. 7, pp. 1237-1247

  5. Validation and clinical evaluation of an ultra-performance liquid chromatography with ultraviolet detector method for plasma quantification of micafungin

    Annals of Clinical Biochemistry, Vol. 60, Núm. 3, pp. 191-198

2022

  1. External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1913-1924

  2. Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study

    Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736

  3. Long-term effectiveness and pharmacokinetics of the infliximab biosimilar CT-P13 after switching from the originator during the treatment of inflammatory bowel disease

    European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 222-227

  4. Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

    Journal of Clinical Medicine, Vol. 11, Núm. 2

  5. Population Pharmacokinetics of Valproic Acid in Pediatric and Adult Caucasian Patients

    Pharmaceutics, Vol. 14, Núm. 4

  6. Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients

    European Journal of Pharmaceutical Sciences, Vol. 168

  7. Process of medical nutrition therapy

    Nutricion Hospitalaria, Vol. 39, Núm. 5, pp. 1166-1189

  8. Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab

    Journal of Clinical Medicine, Vol. 11, Núm. 15

2021

  1. Comparison of ultra-performance liquid chromatography and ARK immunoassay for therapeutic drug monitoring of voriconazole

    Annals of Clinical Biochemistry, Vol. 58, Núm. 6, pp. 657-660

  2. Estudio multicéntrico de la incidencia y evitabilidad de los incidentes por medicamentos en pacientes que acuden a los servicios de urgencias pediátricas

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 3, pp. 115-120

  3. Evaluation of current amikacin dosing recommendations and development of an interactive nomogram: The role of albumin

    Pharmaceutics, Vol. 13, Núm. 2, pp. 1-13

  4. Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity

    European Journal of Hospital Pharmacy, Vol. 28, Núm. e1, pp. E41-E46

  5. Validation and Comparison of Two Analytical Methods for Imatinib Therapeutic Drug Monitoring

    Chromatographia, Vol. 84, Núm. 6, pp. 589-596

  6. Value of skin tests for managing allergic hypersensitivity reactions to platinum compounds

    International Journal of Clinical Pharmacy, Vol. 43, Núm. 4, pp. 1123-1127